Archived Newsletters
-
11.10.25 -- Considerations For Realizing A Successful Combination Products Program
11/10/2025
11/10/25 Outsourced Pharma Newsletter
-
11.10.25 -- STREAM Edition: Supply Chain Due Diligence Before Acquiring Bio Assets
11/10/2025
11/10/25 Outsourced Pharma Newsletter
-
11.10.25 -- Cell & Gene Therapy Outsourcing's New Paradigm
11/10/2025
11/10/25 Outsourced Pharma Newsletter
-
11.08.25 -- Outsourced Pharma Best Of October
11/8/2025
11/08/25 Outsourced Pharma Newsletter
-
11.07.25 -- New Podcast Episodes: Blocking Neuroinflammation, BoB In South Florida, Sanofi's Genomic Medicine Vision
11/7/2025
11/07/25 Outsourced Pharma Newsletter
-
11.07.25 -- Will It Not Die? The BIOSECURE Act Back With Iterations
11/7/2025
11/07/25 Outsourced Pharma Newsletter
-
11.06.25 -- Closing The Gap Between Discovery And Delivery
11/6/2025
11/06/25 Outsourced Pharma Newsletter
-
11.06.25 -- The 9 Fastest-Growing Outsourcing Segments
11/6/2025
11/06/25 Outsourced Pharma Newsletter
-
11.05.25 -- Amorphous Solid Dispersions: High Loading, Better Bioavailability, Smart Testing
11/5/2025
11/05/25 Outsourced Pharma Newsletter
-
11.05.25 -- The Science Behind Stable & Effective ADCs
11/5/2025
11/05/25 Outsourced Pharma Newsletter